Equity Overview
Price & Market Data
Price: $5.00
Daily Change: $0.00 / 0.00%
Daily Range: $5.00 - $5.00
Market Cap: $45,161,460
Daily Volume: 288
Performance Metrics
1 Week: -0.20%
1 Month: 19.62%
3 Months: 159.1%
6 Months: 98.41%
1 Year: 163.2%
YTD: 168.8%
Company Details
Employees: 21
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.